Device product
Leccurate SARS-CoV-2, Antigen Rapid Test Kit (Colloidal Gold Immunochromatography), 1 test, IVD. for the qualitative detection of antigen SARS-CoV-2 in clinical samples (nasal swab).
Z-1620-2021
Product summary
- Event
- Event 87737
- Status
- Completed
- Classification
- Class I
- Quantity
- 8, 419, 545 units in total
- Official record key
device-enforcement:Z-1620-2021
Official wording
Reason: Antigen Rapid Test Kit is not authorized, cleared, or approved for marketing and/or distribution in the U.S.
Code information: All Lots distributed within the U.S.
Distribution pattern: Worldwide Distribution: US Distribution to states of: FL, IL, NY, GA, Puerto Rico and OUS countries of: Canada, Honduras, Peru, Dominican, Bolivia, Colombia, Mexico, Brazil, Argentina, Guatemala, Venezuela, Ecuador, Chile, Paraguay, Panama, Costa Rica, Peru and Hong Kong.
Derived failure modes
-
Unknown
Antigen Rapid Test Kit is not authorized, cleared, or approved for marketing and/or distribution in the U.S.